1 terminated. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Terminated 1 |
Follow AB023: new trials by email Literature Review of AB023 trials Research Report on AB023
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Xisomab 3G3 for the Prevention of Catheter-Associated Thrombosis in Patients With Cancer Receiving Chemotherapy Xisomab 3G3 - Lymphoma, Malignant Solid Neoplasm | Phase 2 | Terminated | OHSU Knight Cancer Institute | 9 | 2021-02-25 | 2024-01-24 |
Lymphoma (1) · Multiple Myeloma (1)
OHSU Knight Cancer Institute (1)
United States (1)
R01HL151367 (1)